NCT06405438

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome

Name: Clinical Trial NCT06405438
Creator: Beylikduzu State Hospital
Keywords: Carpal Tunnel Syndrome, physical therapy, other, clinical trial, Turkey

Comparison of the Efficacy of Peloid Therapy and Paraffin Treatment in Carpal Tunnel Syndrome: A Randomized Prospective Clinical Study

Beylikduzu State Hospital·ClinicalTrials.gov·otherNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Carpal Tunnel Syndrome
Drug/Device/Intervention: physical therapy
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: Beylikduzu State Hospital
Location: Istanbul, Turkey

Timeline & enrollment

Phase: N/A
Start date: Jun 01, 2024
End date: Oct 01, 2024
Enrollment: 60 participants

Primary outcome

Boston Carpal Tunnel Syndrome Questionnaire

Summary

This study compares the effectiveness of peloid therapy and paraffin treatment in carpal tunnel syndrome. Patients receive either 2 weeks of peloid therapy or 15 sessions of paraffin treatment, along with splint therapy for 3 months. Pain and symptom severity are assessed using the Visual Analog Scale (VAS) and Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Results are measured at baseline, 4 weeks post-treatment, and a 12-week follow-up.

ICD-10 classifications

Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06405438
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06405438 through Pure Global AI's free database. This phase not specified trial is sponsored by Beylikduzu State Hospital and is currently Not yet recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.